MAAT PHARMA | WebDisclosure

Basculer en Français

11336	Companies
251966	Keywords
181326	Articles
137794	Press releases

Home
Companies
MAAT PHARMA

PRESS RELEASE

published on 09/20/2024 at 09:07, 2 years 1 month ago

Rapport Financier Semestriel 2024
BRIEF

published on 09/04/2024 at 07:35, 2 years 2 months ago

MaaT Pharma annonce sa participation à des conférences investisseurs et médicales en septembre

Investisseurs Conférence Médicale Thérapies MET Transplantation Cellulaire Cancers
BRIEF

published on 09/04/2024 at 07:35, 2 years 2 months ago

MaaT Pharma Announces Participation in Investor and Medical Conferences in September

Investors Cancers Medical Conference MET Therapies Cell Transplantation
PRESS RELEASE

published on 09/04/2024 at 07:30, 2 years 2 months ago

Informations privilégiées / Autres communiqués
MaaT Pharma annonce sa participation aux conférences investisseurs et médicales en septembre, avec des présentations lors du Congrès annuel de la Society of Hematologic Oncology à Houston et à d'autres événements internationaux

Conférences Investisseurs Microbiote MaaT Pharma Cancers
BRIEF

published on 05/15/2024 at 07:35, 2 years 6 months ago

MaaT Pharma clôture avec succès une levée de fonds de 19,2 millions d'euros

Investissement Biotechnologie Essais Cliniques Levée De Fonds MaaT Pharma
BRIEF

published on 05/15/2024 at 07:35, 2 years 6 months ago

MaaT Pharma successfully completes a fundraising of 19.2 million euros

Biotechnology Fundraising Investment MaaT Pharma Clinical Tests
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 6 months ago

Informations privilégiées / Communiqué sur comptes, résultats
MaaT Pharma annonce le succès de son offre globale de 19,2 millions d'euros pour financer ses activités de R&D en biotechnologie clinique avancée, incluant des essais cliniques et le développement de son portefeuille thérapeutique

Essais Cliniques Offre Globale MaaT Pharma Biotechnologie Clinique Portefeuille Thérapeutique
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 6 months ago

Inside Information / News release on accounts, results
MaaT Pharma announces successful completion of 19.2 million euros Global Offering with new shares, aims to fund R&D activities, Phase 3 trials, and broaden pipeline

Biotechnology Fundraising Clinical Trials Global Offering MaaT Pharma
BRIEF

published on 05/14/2024 at 19:39, 2 years 6 months ago

MaaT Pharma Announces 18 Million Euro Global Offering and Strategic Developments

Financial Strategy Phase 3 Trial Clinical-stage Biotechnology Global Offering Microbiome Ecosystem Therapies
BRIEF

published on 05/14/2024 at 19:39, 2 years 6 months ago

MaaT Pharma annonce une offre mondiale et des développements stratégiques de 18 millions d'euros

Stratégie Financière Essai De Phase 3 Offre Globale Thérapies Écosystémiques Du Microbiome Biotechnologie Au Stade Clinique

Accesswire

Published on 11/14/2026 at 12:56, 23 hours 25 minutes ago

Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day 10 hours ago

NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 11 hours ago

BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 11 hours ago

American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 12 hours ago

SLAM Announces Proposed Extension of Warrant Expiry Dates

View all ACCESSWIRE

EQS Group

Published on 11/13/2026 at 23:24, 1 day 12 hours ago

EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 14 hours ago

EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:15, 1 day 17 hours ago

Increase in Equity to Accelerate Growth
Published on 11/13/2026 at 19:08, 1 day 17 hours ago

EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 17 hours ago

Assemblée générale ordinaire des actionnaires le 18 décembre 2026

Les Echos

Published on 11/13/2026 at 17:45, 1 day 18 hours ago

STEF : Droits de vote au 31-10-2026
Published on 11/13/2026 at 11:35, 2 days ago

ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 2 days ago

ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 2 days 4 hours ago

Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 13 hours ago

Belgrano continues the implementation of its public share buyback offer (OPRA)

View all LES ECHOS COMFI WIRE